SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 409 filers reported holding SAREPTA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $942 | -94.8% | 14 | -89.4% | 0.00% | – |
| Q1 2023 | $18,194 | -99.6% | 132 | -99.5% | 0.00% | -100.0% |
| Q4 2020 | $4,993,000 | +76.2% | 29,288 | +45.2% | 0.10% | +53.2% |
| Q3 2020 | $2,833,000 | -23.9% | 20,174 | -13.1% | 0.06% | -29.5% |
| Q2 2020 | $3,723,000 | +57.0% | 23,222 | -4.2% | 0.09% | +29.4% |
| Q1 2020 | $2,371,000 | -4.1% | 24,235 | +26.5% | 0.07% | +21.4% |
| Q4 2019 | $2,472,000 | -38.4% | 19,157 | -27.5% | 0.06% | -41.7% |
| Q2 2019 | $4,014,000 | +55.0% | 26,415 | +21.6% | 0.10% | +54.8% |
| Q1 2019 | $2,589,000 | +783.6% | 21,721 | +708.7% | 0.06% | +675.0% |
| Q4 2018 | $293,000 | -86.8% | 2,686 | -80.4% | 0.01% | -85.7% |
| Q3 2018 | $2,217,000 | -6.5% | 13,731 | -67.8% | 0.06% | -13.8% |
| Q4 2017 | $2,372,000 | +49.6% | 42,631 | +21.9% | 0.06% | +41.3% |
| Q3 2017 | $1,586,000 | – | 34,972 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Perceptive Advisors | 2,878,979 | $69,182,000 | 7.27% |
| Eventide Asset Management | 259,100 | $6,226,000 | 0.97% |
| GLADE BROOK CAPITAL PARTNERS LLC | 251,000 | $6,032,000 | 0.93% |
| IMS Capital Management | 32,215 | $774,000 | 0.91% |
| Perceptive Advisors | 350,000 | $8,413,000 | 0.88% |
| Benchmark Capital Advisors | 34,900 | $839,000 | 0.58% |
| BECK CAPITAL MANAGEMENT, LLC | 24,744 | $636,000 | 0.49% |
| SABBY MANAGEMENT, LLC | 352,100 | $8,461,000 | 0.47% |
| Hatteras Alternative Mutual Funds, LLC | 39,404 | $947,000 | 0.46% |
| Potomac Capital Management, Inc. | 22,100 | $531,000 | 0.45% |